Early Edition with Ryan BridgeEarly Edition with Ryan Bridge

Rosamund Hill: Neurologist on the new anti-migraine medication costing kiwis $300 a month

View descriptionShare
 

New and effective anti-migraine drugs aren't publicly funded in New Zealand, costing those with chronic migraine nearly $300 a month. 

An Otago University survey suggests almost half of those with the disease meet the criteria for severe disability.  

Some report paralysis on one side of the body and loss of coherent speech. 

Neurologist Rosamund Hill told Mike Hosking that the medicine's publicly funded in Australia. 

She says it's feasible for Pharmac to identify those at the worst end of the spectrum, and how these drugs would significantly change their lives. 

LISTEN ABOVE 

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Early Edition with Ryan Bridge

A fresh and intelligent start to your day - catch the very latest international and domestic news de 
Social links
Follow podcast
Recent clips
Browse 4,990 clip(s)